Medicure Statistics
Total Valuation
Medicure has a market cap or net worth of CAD 9.18 million. The enterprise value is 5.22 million.
Market Cap | 9.18M |
Enterprise Value | 5.22M |
Important Dates
The next estimated earnings date is Wednesday, April 9, 2025.
Earnings Date | Apr 9, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Medicure has 10.44 million shares outstanding. The number of shares has decreased by -8.45% in one year.
Current Share Class | n/a |
Shares Outstanding | 10.44M |
Shares Change (YoY) | -8.45% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 25.26% |
Owned by Institutions (%) | 0.62% |
Float | 5.24M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.44 |
PB Ratio | 0.46 |
P/TBV Ratio | 1.05 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -2.57 |
EV / Sales | 0.25 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.03, with a Debt / Equity ratio of 0.05.
Current Ratio | 2.03 |
Quick Ratio | 1.45 |
Debt / Equity | 0.05 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -123.68 |
Financial Efficiency
Return on equity (ROE) is -9.72% and return on invested capital (ROIC) is -11.04%.
Return on Equity (ROE) | -9.72% |
Return on Assets (ROA) | -8.36% |
Return on Capital (ROIC) | -11.04% |
Revenue Per Employee | 554,816 |
Profits Per Employee | -53,526 |
Employee Count | 38 |
Asset Turnover | 0.74 |
Inventory Turnover | 2.79 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.14% in the last 52 weeks. The beta is 0.90, so Medicure's price volatility has been lower than the market average.
Beta (5Y) | 0.90 |
52-Week Price Change | -37.14% |
50-Day Moving Average | 0.92 |
200-Day Moving Average | 1.07 |
Relative Strength Index (RSI) | 29.65 |
Average Volume (20 Days) | 635 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicure had revenue of CAD 21.08 million and -2.03 million in losses. Loss per share was -0.20.
Revenue | 21.08M |
Gross Profit | 12.01M |
Operating Income | -3.83M |
Pretax Income | -1.94M |
Net Income | -2.03M |
EBITDA | -2.15M |
EBIT | -3.83M |
Loss Per Share | -0.20 |
Balance Sheet
The company has 4.90 million in cash and 930,000 in debt, giving a net cash position of 3.97 million or 0.38 per share.
Cash & Cash Equivalents | 4.90M |
Total Debt | 930,000 |
Net Cash | 3.97M |
Net Cash Per Share | 0.38 |
Equity (Book Value) | 19.98M |
Book Value Per Share | 1.91 |
Working Capital | 8.19M |
Cash Flow
Operating Cash Flow | -5,000 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 56.98%, with operating and profit margins of -18.19% and -9.65%.
Gross Margin | 56.98% |
Operating Margin | -18.19% |
Pretax Margin | -9.20% |
Profit Margin | -9.65% |
EBITDA Margin | -10.19% |
EBIT Margin | -18.19% |
FCF Margin | n/a |
Dividends & Yields
Medicure does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 8.45% |
Shareholder Yield | 8.45% |
Earnings Yield | -22.29% |
FCF Yield | n/a |
Stock Splits
The last stock split was on November 2, 2012. It was a reverse split with a ratio of 0.0666666.
Last Split Date | Nov 2, 2012 |
Split Type | Reverse |
Split Ratio | 0.0666666 |
Scores
Medicure has an Altman Z-Score of -1.7. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.7 |
Piotroski F-Score | n/a |